As an adjunct to the gene mapping projects described in this application and as a technique development project by the Genetic Resources CORE, we propose to refine and apply new methods for the detection of DNA polymorphisms. We believe that these methods will permit the detection of nearly all base substitutions in selected regions of the genome and will provide a new database of polymorphisms for linkage studies. These techniques should simplify and reduce the cost of DNA analysis not only for mapping studies but for such applications as paternity testing, carrier detection of inherited disorders, prenatal diagnosis, and identification of somatic mutations in various neoplastic disorders. In addition, these methods should allow a more thorough determination of the extent of variation in human populations. Briefly, small regions of DNA will be amplified by the polymerase chain reaction (PCR) technique and assayed for specific base substitutions. First, PCR amplified DNA would be tested for polymorphisms with frequent cutting restriction endonucleases not generally acrylamide gels either directly following amplification or after mixing and reannealing with amplified DNA from individuals with known alleles. Allelic differences or mismatches between dissimilar strands would be identified by their relative melting positions. Lastly, selected samples would be compared by direct sequencing of the PCR amplified products. These various approaches would be compared (particularly the first and second) to determine the optimum method for detecting variation. On the basis of this information we would develop a new database of polymorphisms at particular chromosomal locations. This would be augmented by designing amplifying primers based on known polymorphic sequences and by determining the sequence around polymorphic sites in probes currently used for RFLP analysis. Two classes of PCR identifiable polymorphisms (PIPs) are expected to emerge, those detected by restriction enzyme digestion and others that will be detected most easily using allele specific oligos (ASOs). The combined library of PIPs would then be applied to the mapping projects described in the accompanying projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
1P01GM041015-01
Application #
3919176
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Pyeritz, R E (1993) Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations. Semin Thorac Cardiovasc Surg 5:11-6
DiLella, A G; Hawkins, A; Craig, R J et al. (1992) Chromosomal band assignments of the genes encoding human FKBP12 and FKBP13. Biochem Biophys Res Commun 189:819-23
Amelung, P J; Panhuysen, C I; Postma, D S et al. (1992) Atopy and bronchial hyperresponsiveness: exclusion of linkage to markers on chromosomes 11q and 6p. Clin Exp Allergy 22:1077-84
Dietz, H C; Pyeritz, R E; Puffenberger, E G et al. (1992) Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest 89:1674-80
Dietz, H C; Saraiva, J M; Pyeritz, R E et al. (1992) Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum Mutat 1:366-74
Montrose-Rafizadeh, C; Blackmon, D L; Hamosh, A et al. (1992) Regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gene transcription and alternative RNA splicing in a model of developing intestinal epithelium. J Biol Chem 267:19299-305
Finkelstein, J E; Doege, K; Yamada, Y et al. (1991) Analysis of the chondroitin sulfate proteoglycan core protein (CSPGCP) gene in achondroplasia and pseudoachondroplasia. Am J Hum Genet 48:97-102
Jabs, E W; Warren, A C; Taylor, E W et al. (1991) Alphoid DNA polymorphisms for chromosome 21 can be distinguished from those of chromosome 13 using probes homologous to both. Genomics 9:141-6
Jabs, E W; Coss, C A; Hayflick, S J et al. (1991) Chromosomal deletion 4p15.32----p14 in a Treacher Collins syndrome patient: exclusion of the disease locus from and mapping of anonymous DNA sequences to this region. Genomics 11:188-92
Petersen, M B; Adelsberger, P A; Schinzel, A A et al. (1991) Down syndrome due to de novo Robertsonian translocation t(14q;21q): DNA polymorphism analysis suggests that the origin of the extra 21q is maternal. Am J Hum Genet 49:529-36

Showing the most recent 10 out of 14 publications